login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ACURX PHARMACEUTICALS INC (ACXP) Stock News
USA
-
Nasdaq
- NASDAQ:ACXP -
US00510M2035
-
Common Stock
3.59
USD
-0.29 (-7.47%)
Last: 12/1/2025, 8:00:00 PM
3.5617
USD
-0.03 (-0.79%)
After Hours:
12/1/2025, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ACXP Latest News, Press Relases and Analysis
All
Press Releases
9 days ago - By: ACCESS Newswire
- Mentions:
RDZN
NRXP
AERT
CISO
New to The Street Show #702 Airs Today on Bloomberg at 6:30 PM EST
16 days ago - By: ACCESS Newswire
- Mentions:
DVLT
PTOP
New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television
20 days ago - By: Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update
20 days ago - By: Benzinga
- Mentions:
GWRS
IMRX
DYAI
LEGN
...
Earnings Scheduled For November 12, 2025
22 days ago - By: Acurx Pharmaceuticals, Inc.
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens
a month ago - By: Acurx Pharmaceuticals, Inc.
Acurx Announces New Data on its DNA pol IIIC Inhibitor Antibiotics Demonstrating a Potential Class Effect of Gut Microbiome Selectivity Presented at IDWeek 2025 Scientific Conference
a month ago - By: Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update
a month ago - By: ACCESS Newswire
- Mentions:
LASE
PETV
AERT
DVLT
...
New to The Street to Broadcast Nationwide on Bloomberg TV Tonight at 6:30 PM EST Featuring Roadzen, Spartan Equipment, XION, Metaterra, and YY Group
a month ago - By: ACCESS Newswire
- Mentions:
SDST
RDZN
AERT
SNYR
...
New to The Street Show #694 to Broadcast Tonight at 6:30 PM EST as Sponsored Programming on Bloomberg TV Featuring Stardust Power (NASDAQ:SDST), Spartan Equipment, Roadzen (NASDAQ:RDZN), Aeries Technology (NASDAQ:AERT), and XION
4 months ago - By: Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc. Reports Second Quarter Results and Provides Business Update
4 months ago - By: Benzinga
Earnings Preview: Acurx Pharmaceuticals
4 months ago - By: Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc. Announces Reverse Stock Split
2 months ago - By: ACCESS Newswire
- Mentions:
SNYR
DVLT
PETV
RDZN
...
Meet the Companies - New to The Street's Accredited Investor Event Returns October 21-22 at Hudson Yards, NYC
2 months ago - By: Acurx Pharmaceuticals, Inc.
Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors
2 months ago - By: ACCESS Newswire
- Mentions:
NTHI
STSS
AERT
LASE
...
New to The Street to Broadcast Tonight on Fox Business 10:30 PM PST Featuring NeOnc Technologies, FLOKI, XION, Sharps Technology, and Aeries Technology
2 months ago - By: ACCESS Newswire
- Mentions:
SGTM
LASE
DVLT
PETV
...
New to The Street to Broadcast Nationwide on Bloomberg Tonight at 6:30 PM EST
2 months ago - By: Acurx Pharmaceuticals, Inc.
Acurx Announces Positive Opinion from EMA on Pediatric Investigation Plan for Ibezapolstat Use in Children with C. difficile Infection
2 months ago - By: ACCESS Newswire
- Mentions:
NTHI
STSS
AERT
LASE
...
New to The Street to Broadcast Saturday, September 27th Featuring NeOnc Pharma $NTHI and Other Innovative Companies
3 months ago - By: ACCESS Newswire
- Mentions:
NTHI
STSS
LASE
TONX
...
New to The Street to Broadcast Episode 686 Tonight on Bloomberg Television at 6:30 PM EST
3 months ago - By: ACCESS Newswire
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events
3 months ago - By: ACCESS Newswire
- Mentions:
TONX
LASE
MFH
SNYR
...
New to The Street T.V. Broadcasting on Bloomberg Saturday Aug 30th. The episode features TON Strategy Company (NASDAQ: TONX), Laser Photonics (NASDAQ: LASE), Sullivan & Cromwell Senior M&A Partner Frank Aquila, and Mercurity Fintech (NASDAQ: MFH)
4 months ago - By: ACCESS Newswire
- Mentions:
ARAI
PETV
RDZN
SNYR
New to The Street TV Commercial Campaigns Achieve Millions of Views with 87% Average Completion Rate
4 months ago - By: Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 12, 2025 Conference Call and Provide Business Update
5 months ago - By: ACCESS Newswire
- Mentions:
BIVI
AIMD
New to The Street Announces the Broadcast of Show Number 675 This Saturday at 6:30 PM EST on Bloomberg Television Featuring: FLOKI, BioVie (NASDAQ: BIVI), Arrive AI ($ARAI), Health In Tech (NASDAQ HIT), and Commercialville T.V.
Please enable JavaScript to continue using this application.